Geron Corporation (NASDAQ: GERN) could find itself back in favor now that the ban on stem cell funding has been lifted. More importantly, its CEO is giving a keynote speech at the 2010 WORLD STEM CELL SUMMIT this week in Detroit. What will be discussed is not known but chances are that the CEO won’t just say that stem cells offer a bright future to science. At $5.45, the implied stem cell public company sector leader has a 52-week range of $4.37 to $7.18.
Gymboree Corp. (NASDAQ: GYMB) saw a huge surge on Friday of 20% on 10-times normal trading volume to $49.86 and the 52-week trading range is $37.26 to $55.27. All of this was on a possibility that the firm was putting itself up for sale, and based upon the reaction it seems a safe bet that it could announce a formal exploration of a sale this coming week.
JPMorgan Chase & Co. (NYSE: JPM) was featured positively this weekend in Barron’s as Andrew Bary wrote, “Even under stricter regulation and tougher capital-adequacy rules, the bank should do well and be able to boost its dividend, says CEO Jamie Dimon.” At $38.81, its 52-week range is $35.16 to $48.20.
Monsanto Co. (NYSE: MON) cannot win for losing when it comes to its share performance tied to issues over its new corn yields and over ongoing fears about Round-Up’s ties to health concerns. At $48.26, its 52-week range is 44.61 to $87.06. Thomson Reuters has estimates of -$0.06 EPS and $1.82 billion in revenue. Just 90 and 60 days ago the company was expected to be profitable and now the questions looms over whether the forward $2.84 EPS for AUG-2011 has come down enough as the estimate was $3.02 just 90-days ago.
National Bank of Greece SA (NYSE: NBG) could be a secondary beneficiary of a Greek support mechanism from none other than the Chinese. Chinese Premier Wen Jiabao said on a visit to Greece that China will continue to buy Greek bonds and that China will create a $5 billion fund to help Greek shipping companies buy Chinese ships. At $2.25, the 52-week range is $2.11 to $8.37. The question is whether Ireland’s woes bring down the rest of the PIIGS.
Netflix Inc. (NASDAQ: NFLX) may feel additional pressure this coming week as analysts continue to struggle with its valuation and as the stock is now about $20.00 off the high since Thursday. Oddly enough, IBD kept it as the #1 stock chart on the IBD 100, which makes it one of the longest streaks we have seen with the same leader.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.